Get the Stockscreener App
70.19
0.18%
-0.19
Ishares U S Pharmaceuticals Etf stock is traded at $70.19, with a volume of 57,186.
It is down -0.18% in the last 24 hours and up +6.58% over the past month.
See More
Previous Close:
$70.38
Open:
$70.42
24h Volume:
57,186
Relative Volume:
0.88
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.17%
1M Performance:
+6.58%
6M Performance:
+5.75%
1Y Performance:
+5.97%
1-Day Range:
$70.21
$70.82
1-Week Range:
$68.66
$71.09
52-Week Range:
$62.67
$72.94
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Name
Ishares U S Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare IHE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
70.25 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
298.09 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
600.83 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
603.76 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
247.71 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
523.10 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Stock (IHE) Latest News
U.S. Capital Wealth Advisors LLC Has $390,000 Stock Holdings in Cambria Shareholder Yield ETF (BATS:SYLD) - ETF Daily News
DAVENPORT & Co LLC Has $722,000 Position in iShares S&P 500 Value ETF (NYSEARCA:IVE) - ETF Daily News
(IHE) Technical Pivots with Risk Controls - Stock Traders Daily
What Are Wall Street Analysts’ Target Price For Merck Stock? - Barchart
What Are Wall Street Analysts’ Target Price for Merck Stock? - Inkl
These ETFs can help investors protect themselves from selloffs like the DeepSeek panic — but here’s the catch - MarketWatch
iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Position Lessened by JPMorgan Chase & Co. - Defense World
How to Take Advantage of moves in (IHE) - Stock Traders Daily
Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery - Benzinga
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - MSN
ETFs Poised To Win Or Lose Under Trump's New Policies - Barchart
Barclays PLC Raises Stock Holdings in LifeVantage Co. (NASDAQ:LFVN) - Defense World
Treasury Metals (OTCMKTS:TSRMD) Stock Price Down 2.5% – Should You Sell? - Defense World
Franklin Resources Inc. Has $2.35 Million Holdings in Mach Natural Resources LP (NYSE:MNR) - Defense World
JPMorgan Chase & Co. Buys 75,592 Shares of First Trust Ultra Short Duration Municipal ETF (NYSEARCA:FUMB) - Defense World
Wealth Enhancement Advisory Services LLC Buys New Position in ALPS Disruptive Technologies ETF (NYSEARCA:DTEC) - Defense World
Wealth Enhancement Advisory Services LLC Has $299,000 Stock Position in Darling Ingredients Inc. (NYSE:DAR) - Defense World
Wealth Enhancement Advisory Services LLC Raises Stock Position in iShares U.S. Basic Materials ETF (NYSEARCA:IYM) - Defense World
Wealth Enhancement Advisory Services LLC Has $318,000 Stock Holdings in iShares MSCI China ETF (NASDAQ:MCHI) - Defense World
Wealth Enhancement Advisory Services LLC Acquires New Holdings in Invesco BulletShares 2027 Municipal Bond ETF (NASDAQ:BSMR) - Defense World
Wealth Enhancement Advisory Services LLC Raises Stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Cyclacel Pharmaceuticals (NASDAQ:CYCC) Coverage Initiated at StockNews.com - Defense World
JPMorgan Chase & Co. Purchases 198,288 Shares of Columbia Diversified Fixed Income Allocation ETF (NYSEARCA:DIAL) - Defense World
JPMorgan Chase & Co. Sells 10,454 Shares of Invesco S&P 500 High Beta ETF (NYSEARCA:SPHB) - Defense World
Vanguard Short-Term Tax-Exempt Bond ETF (NYSEARCA:VTES) Holdings Raised by JPMorgan Chase & Co. - Defense World
JPMorgan Chase & Co. Has $4.38 Million Holdings in iShares U.S. Transportation ETF (BATS:IYT) - Defense World
JPMorgan Chase & Co. Sells 47,417 Shares of SPDR Portfolio Corporate Bond ETF (NYSEARCA:SPBO) - Defense World
JPMorgan Chase & Co. Sells 22,848 Shares of Vanguard Long-Term Bond ETF (NYSEARCA:BLV) - Defense World
100,000 Shares in JPMorgan Dividend Leaders ETF (NYSEARCA:JDIV) Acquired by JPMorgan Chase & Co. - Defense World
Canaccord Genuity Group Issues Pessimistic Forecast for Aspen Aerogels (NYSE:ASPN) Stock Price - Defense World
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - MSN
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
Long Term Trading Analysis for (IHE) - Stock Traders Daily
Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip - Barchart
Eli Lilly Lowers Q4 Sales Outlook: Best ETFs to Consider Now - espeaks.co.uk
6 Best Health Care ETFs to Buy for 2025 | Investing - U.S News & World Report Money
Objective long/short (IHE) Report - Stock Traders Daily
John Marshall Bancorp, Inc. (NASDAQ:JMSB) Shares Purchased by Barclays PLC - Defense World
LAVA Therapeutics NV Files 8-K with SEC, Transitioning to U.S. Domestic Issuer Status - Defense World
iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Shares Bought by Jane Street Group LLC - Defense World
Jane Street Group LLC Cuts Stock Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - Defense World
Top U.S. health care mid-cap stocks and their Quant Ratings (NYSEARCA:IYH) - Seeking Alpha
How the (IHE) price action is used to our Advantage - Stock Traders Daily
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - MSN
iShares Emerging Markets Infrastructure ETF declares semi-annual distribution of $0.4838 - MSN
J.P. Morgan’s top Healthcare stocks for 2025 (NYSEARCA:XLV) - Seeking Alpha
Fmr LLC Acquires 1,338 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) - Defense World
Fmr LLC Has $1.21 Million Stock Position in iShares MSCI Europe Financials ETF (NASDAQ:EUFN) - Defense World
IHF: Healthcare Dashboard For December (NYSEARCA:IHF) - Seeking Alpha
Analyzing United States Antimony (NYSE:UAMY) and Stardust Power (NASDAQ:SDST) - Defense World
Trend Tracker for (IHE) - Stock Traders Daily
Ishares U S Pharmaceuticals Etf Stock (IHE) Financials Data
There is no financial data for Ishares U S Pharmaceuticals Etf (IHE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):